Remsima®

Remsima® is a biosimilar anti-TNF alpha used in rheumatology and gastro-enterology. Developed by Celltrion Healthcare, it was approved for sale in Switzerland in 2015. It is a Class A drug that must be stored between 2°C and 8°C. Remsima is administered intravenously.
Remsima-infliximab 100mg

Request brochure for healthcare professionals
Yuflyma®

Yuflyma® is a biosimilar anti-TNF alpha used in rheumatology, gastro-enterology, dermatology & ophtalmology. Developed by Celltrion Healthcare, it was approved in Switzerland in 2022. It is a Class B drug that must be stored between 2°C and 8°C. Yuflyma is administered subcutaneously and is available in prefilled pen and prefilled syringe with needle guard.
Yuflyma-adalimumab 40mg/0.4ml

Request brochure for healthcare professionals
Truxima®

Truxima® is a biosimilar monoclonal antibody designed to target the CD20 antigen. It was developed by Celltrion Healthcare for use in hematology, rheumatology and oncology, and received market approval in Switzerland in 2019. It is a Class A drug that must be stored between 2°C and 8°C. Truxima® is administered intraveneously.
Truxima-rituximab 100mg and 500mg

Services for healthcare providers
We provide you with everything you need to know about our products so that you can properly inform and treat your patients: how the products are manufactured and shipped, indications, potential side effects, storage and use, training and documentation, and ongoing support. We answer your questions, find solutions and deliver on what we promise.
product name - molecule

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris efficitur augue non ligula sagittis tristique. Donec sagittis feugiat libero, nec rhoncus purus euismod vitae.

Request our fact sheet for healthcare professionals

Download our fact sheet for patients
Speak with one of our experts
If you are a Healthcare Professional, our team will be happy to have a chat with you.

Martin Dom
Commercial Manager Immunology Switzerland +41 76 322 69 60 martin.dom@iqone-healthcare.com

David Modoux
Commercial Manager Immunology Switzerland +41 78 889 80 64 david.modoux@iqone-healthcare.com